FIELD: chemistry.
SUBSTANCE: invention relates to immunology and biotechnology. Described are versions of the humanised antibody CD45RO/RB which carry a light and a heavy strand. Versions of the following are disclosed: isolated polynucleotide, coding antibody, expression vector containing a polynucleotide and host cells containing the expression vector. Described also is use of the antibody to treat and/or prevent various diseases, including as a component of a pharmaceutical composition.
EFFECT: invention provides antibodies identified as CD45RO and CD45RB, which can find use in medicine.
9 cl, 14 dwg, 2 tbl, 13 ex
Title | Year | Author | Number |
---|---|---|---|
THERAPEUTIC BINDING MOLECULES | 2002 |
|
RU2328506C2 |
HUMANISED AHTH-CD4 ANTIBODY WITH IMMUNOSUPPRESSIVE PROPERTIES | 2004 |
|
RU2375375C2 |
POLYPEPTIDE WITH ANTIVIRAL, ANTIPROLIFERATIVE AND/OR IMMUNOMODULATING ACTIVITIES, SEPARATED POLYNUCLEOTIDE | 2002 |
|
RU2328528C2 |
NOVEL SOLUBLE POLYPEPTIDES CD83, COMPOSITIONS AND METHODS OF THEIR APPLICATION | 2009 |
|
RU2535340C2 |
LIGAND GITR AND MOLECULES AND ANTIBODIES BOUND WITH LIGAND GITR, AND VERSIONS OF THEIR APPLICATION | 2004 |
|
RU2369636C2 |
HIGH AFFINITY AND AGGREGATIONALLY STABLE ANTIBODIES BASED ON VL VARIABLE DOMAINS AND VHH DERIVATIVE | 2014 |
|
RU2609627C2 |
ANTI-IL-17 ANTIBODIES, METHODS OF THEIR PRODUCTION AND APPLICATION | 2014 |
|
RU2577228C2 |
HUMAN MONOCLONAL ANTIBODIES TO HUMAN INTERLEUKINE-4 (hIL-4) | 2005 |
|
RU2382049C2 |
ANTI-CD40 ANTIBODY MUTANTS | 2004 |
|
RU2377254C2 |
MONOCLONAL ANTIBODIES AGAINST IL-21 OF HUMAN BEING | 2008 |
|
RU2504552C2 |
Authors
Dates
2010-04-20—Published
2004-09-17—Filed